Psilocybin-induced decrease in amygdala reactivity correlates with enhanced positive mood in healthy volunteers

Biological Psychiatry

Volumn 78, Issue 8, 2015, Pages 572-581

  Kraehenmann, Rainer ^a,b   Preller, Katrin H ^a,b   Scheidegger, Milan ^a,b   Pokorny, Thomas ^a,b   Bosch, Oliver G ^a   Seifritz, Erich ^a   Vollenweider, Franz X ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

Author keywords

Amygdala; Depression; Emotion; fMRI; Psilocybin; Serotonin

Indexed keywords

PLACEBO; PSILOCYBINE; PSYCHEDELIC AGENT;

ADULT; AMYGDALOID NUCLEUS; ANTIDEPRESSANT ACTIVITY; ARTICLE; BOLD SIGNAL; BRAIN ANALYSIS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ELECTROENCEPHALOGRAM; EMOTION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; MAJOR DEPRESSION; MALE; MOOD CHANGE; NERVE POTENTIAL; NORMAL HUMAN; OXYGEN BLOOD LEVEL; POSITIVE AND NEGATIVE AFFECT SCHEDULE; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATE TRAIT ANXIETY INVENTORY; VISUAL HALLUCINATION; AFFECT; AMYGDALA; DEPRESSION; DRUG EFFECTS; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; YOUNG ADULT;

ADULT; AFFECT; AMYGDALA; CROSS-OVER STUDIES; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; HALLUCINOGENS; HEALTHY VOLUNTEERS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PSILOCYBINE; PSYCHIATRIC STATUS RATING SCALES; YOUNG ADULT;

EID: 84941758943     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2014.04.010     Document Type: Article

References (82)

1. R.J. DeRubeis, G.J. Siegle, and S.D. Hollon Cognitive therapy versus medication for depression: Treatment outcomes and neural mechanisms Nat Rev Neurosci 9 2008 788 796
2. E.A. Phelps, and J.E. LeDoux Contributions of the amygdala to emotion processing: From animal models to human behavior Neuron 48 2005 175 187
3. W. Ramel, P.R. Goldin, L.T. Eyler, G.G. Brown, I.H. Gotlib, and J.R. McQuaid Amygdala reactivity and mood-congruent memory in individuals at risk for depressive relapse Biol Psychiatry 61 2007 231 239
4. G.J. Siegle, S.R. Steinhauer, M.E. Thase, V.A. Stenger, and C.S. Carter Can't shake that feeling: Event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals Biol Psychiatry 51 2002 693 707
5. A. Stuhrmann, K. Dohm, H. Kugel, P. Zwanzger, R. Redlich, D. Grotegerd, and et al. Mood-congruent amygdala responses to subliminally presented facial expressions in major depression: Associations with anhedonia J Psychiatry Neurosci 38 2013 249 258
6. C.H. Fu, S.C. Williams, A.J. Cleare, M.J. Brammer, N.D. Walsh, J. Kim, and et al. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: A prospective, event-related functional magnetic resonance imaging study Arch Gen Psychiatry 61 2004 877 889
7. T.A. Victor, M.L. Furey, S.J. Fromm, A. Ohman, and W.C. Drevets Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder Arch Gen Psychiatry 67 2010 1128 1138
8. A.R. Hariri, V.S. Mattay, A. Tessitore, B. Kolachana, F. Fera, D. Goldman, and et al. Serotonin transporter genetic variation and the response of the human amygdala Science 297 2002 400 403
9. A.R. Hariri, E.M. Drabant, K.E. Munoz, B.S. Kolachana, V.S. Mattay, M.F. Egan, and et al. A susceptibility gene for affective disorders and the response of the human amygdala Arch Gen Psychiatry 62 2005 146 152
10. S.E. Murphy, R. Norbury, B.R. Godlewska, P.J. Cowen, Z.M. Mannie, C.J. Harmer, and M.R. Munafò The effect of the serotonin transporter polymorphism (5-HTTLPR) on amygdala function: A meta-analysis Mol Psychiatry 18 2013 512 520
11. M.L. Wong, and J. Licinio Research and treatment approaches to depression Nat Rev Neurosci 2 2001 343 351
12. J.P. Hamilton, A. Etkin, D.J. Furman, M.G. Lemus, R.F. Johnson, and I.H. Gotlib Functional neuroimaging of major depressive disorder: A meta-analysis and new integration of base line activation and neural response data Am J Psychiatry 169 2012 693 703
13. W.C. Drevets Neuroimaging abnormalities in the amygdala in mood disorders Ann N Y Acad Sci 985 2003 420 444
14. A. Hahn, R. Lanzenberger, W. Wadsak, C. Spindelegger, U. Moser, L. Mien, and et al. Escitalopram enhances the association of serotonin-1A autoreceptors to heteroreceptors in anxiety disorders J Neurosci 30 2010 14482 14489
15. F. Hasler, U. Grimberg, M.A. Benz, T. Huber, and F.X. Vollenweider Acute psychological and physiological effects of psilocybin in healthy humans: A double-blind, placebo-controlled dose-effect study Psychopharmacology (Berl) 172 2004 145 156
16. D.E. Nichols Hallucinogens Pharmacol Ther 101 2004 131 181
17. J. González-Maeso, N.V. Weisstaub, M. Zhou, P. Chan, L. Ivic, R. Ang, and et al. Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior Neuron 53 2007 439 452
18. F.X. Vollenweider, and M. Kometer The neurobiology of psychedelic drugs: Implications for the treatment of mood disorders Nat Rev Neurosci 11 2010 642 651
19. M. Kometer, A. Schmidt, R. Bachmann, E. Studerus, E. Seifritz, and F.X. Vollenweider Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors Biol Psychiatry 72 2012 898 906
20. A. Schmidt, M. Kometer, R. Bachmann, E. Seifritz, and F. Vollenweider The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions Psychopharmacology (Berl) 225 2013 227 239
21. F. Bernasconi, A. Schmidt, T. Pokorny, M. Kometer, E. Seifritz, and F.X. Vollenweider Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin [published online ahead of print July 16] Cereb Cortex. 2013
22. R.L. Carhart-Harris, D. Erritzoe, T. Williams, J.M. Stone, L.J. Reed, A. Colasanti, and et al. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin Proc Natl Acad Sci U S A 109 2012 2138 2143
23. R.L. Carhart-Harris, R. Leech, T.M. Williams, D. Erritzoe, N. Abbasi, T. Bargiotas, and et al. Implications for psychedelic-assisted psychotherapy: Functional magnetic resonance imaging study with psilocybin Br J Psychiatry 200 2012 238 244
24. M. Sercl, J. Kovarik, and O. Jaros [Clinical experiences with psilocybin (CY 39 Sandoz)] Psychiatr Neurol (Basel) 142 1961 137 146
25. T.J. Riedlinger, and J.E. Riedlinger Psychedelic and entactogenic drugs in the treatment of depression J Psychoactive Drugs 26 1994 41 55
26. H. Leuner [Psychotherapy with the aid of hallucinogenic drugs] [German] Arzneimittelforschung 16 1966 253 255
27. C.S. Grob, A.L. Danforth, G.S. Chopra, M. Hagerty, C.R. McKay, A.L. Halberstadt, and G.R. Greer Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer Arch Gen Psychiatry 68 2011 71 78
28. U. Dannlowski, P. Ohrmann, J. Bauer, H. Kugel, B.T. Baune, C. Hohoff, and et al. Serotonergic genes modulate amygdala activity in major depression Genes Brain Behav 6 2007 672 676
29. D. Watson, L.A. Clark, and A. Tellegen Development and validation of brief measures of positive and negative affect: The PANAS scales J Pers Soc Psychol 54 1988 1063 1070
30. C.D. Spielberger, and R.L. Gorsuch Manual for the State-Trait Anxiety Inventory (Form Y) ("Self-Evaluation Questionnaire") 1983 Consulting Psychologists Press Palo Alto, CA
31. A.R. Hariri, A. Tessitore, V.S. Mattay, F. Fera, and D.R. Weinberger The amygdala response to emotional stimuli: A comparison of faces and scenes Neuroimage 17 2002 317 323
32. A.R. Hariri, V.S. Mattay, A. Tessitore, F. Fera, and D.R. Weinberger Neocortical modulation of the amygdala response to fearful stimuli Biol Psychiatry 53 2003 494 501
33. P. Kirsch, C. Esslinger, Q. Chen, D. Mier, S. Lis, S. Siddhanti, and et al. Oxytocin modulates neural circuitry for social cognition and fear in humans J Neurosci 25 2005 11489 11493
34. A. Patin, and R. Hurlemann Modulating amygdala responses to emotion: Evidence from pharmacological fMRI Neuropsychologia 49 2011 706 717
35. A.R. Hariri, V.S. Mattay, A. Tessitore, F. Fera, W.G. Smith, and D.R. Weinberger Dextroamphetamine modulates the response of the human amygdala Neuropsychopharmacology 27 2002 1036 1040
36. K.E. Muñoz, A. Meyer-Lindenberg, A.R. Hariri, C.B. Mervis, V.S. Mattay, C.A. Morris, and K.F. Berman Abnormalities in neural processing of emotional stimuli in Williams syndrome vary according to social vs. non-social content Neuroimage 50 2010 340 346
37. N. Tzourio-Mazoyer, B. Landeau, D. Papathanassiou, F. Crivello, O. Etard, N. Delcroix, and et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain Neuroimage 15 2002 273 289
38. J.A. Maldjian, P.J. Laurienti, R.A. Kraft, and J.H. Burdette An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets Neuroimage 19 2003 1233 1239
39. K.J. Worsley, S. Marrett, P. Neelin, A.C. Vandal, K.J. Friston, and A.C. Evans A unified statistical approach for determining significant signals in images of cerebral activation Hum Brain Mapp 4 1996 58 73
40. G.K. Aghajanian, and G.J. Marek Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release Brain Res 825 1999 161 171
41. A.M. Dale, and E. Halgren Spatiotemporal mapping of brain activity by integration of multiple imaging modalities Curr Opin Neurobiol 11 2001 202 208
42. T.D. Wager, K.L. Phan, I. Liberzon, and S.F. Taylor Valence, gender, and lateralization of functional brain anatomy in emotion: A meta-analysis of findings from neuroimaging Neuroimage 19 2003 513 531
43. K. Sergerie, C. Chochol, and J.L. Armony The role of the amygdala in emotional processing: A quantitative meta-analysis of functional neuroimaging studies Neurosci Biobehav Rev 32 2008 811 830
44. D. Baas, A. Aleman, and R.S. Kahn Lateralization of amygdala activation: A systematic review of functional neuroimaging studies Brain Res Brain Res Rev 45 2004 96 103
45. M. Oliveri, and G. Calvo Increased visual cortical excitability in ecstasy users: A transcranial magnetic stimulation study J Neurol Neurosurg Psychiatry 74 2003 1136 1138
46. L.B. Merabet, M. Kobayashi, J. Barton, and A. Pascual-Leone Suppression of complex visual hallucinatory experiences by occipital transcranial magnetic stimulation: A case report Neurocase 9 2003 436 440
47. B. Boroojerdi, K.O. Bushara, B. Corwell, I. Immisch, F. Battaglia, W. Muellbacher, and L.G. Cohen Enhanced excitability of the human visual cortex induced by short-term light deprivation Cereb Cortex 10 2000 529 534
48. D.H. Ffytche, R.J. Howard, M.J. Brammer, A. David, P. Woodruff, and S. Williams The anatomy of conscious vision: An fMRI study of visual hallucinations Nat Neurosci 1 1998 738 742
49. M. Kometer, B.R. Cahn, D. Andel, O.L. Carter, and F.X. Vollenweider The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations Biol Psychiatry 69 2011 399 406
50. M. Kometer, A. Schmidt, L. Jäncke, and F.X. Vollenweider Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations J Neurosci 33 2013 10544 10551
51. D.G. Amaral, H. Behniea, and J.L. Kelly Topographic organization of projections from the amygdala to the visual cortex in the macaque monkey Neuroscience 118 2003 1099 1120
52. P. Vuilleumier, M.P. Richardson, J.L. Armony, J. Driver, and R.J. Dolan Distant influences of amygdala lesion on visual cortical activation during emotional face processing Nat Neurosci 7 2004 1271 1278
53. B. Hornboll, J. Macoveanu, J. Rowe, R. Elliott, O.B. Paulson, H.R. Siebner, and G.M. Knudsen Acute serotonin 2A receptor blocking alters the processing of fearful faces in the orbitofrontal cortex and amygdala J Psychopharmacol 27 2013 903 914
54. F.X. Vollenweider, M.F. Vollenweider-Scherpenhuyzen, A. Bäbler, H. Vogel, and D. Hell Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action Neuroreport 9 1998 3897 3902
55. J.B. Blair, D. Kurrasch-Orbaugh, D. Marona-Lewicka, M.G. Cumbay, V.J. Watts, E.L. Barker, and D.E. Nichols Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines J Med Chem 43 2000 4701 4710
56. H. Sard, G. Kumaran, C. Morency, B.L. Roth, B.A. Toth, P. He, and L. Shuster SAR of psilocybin analogs: Discovery of a selective 5-HT 2C agonist Bioorg Med Chem Lett 15 2005 4555 4559
57. K.A. Michelsen, J. Prickaerts, Steinbusch, and W.M. Harry The dorsal raphe nucleus and serotonin: Implications for neuroplasticity linked to major depression and Alzheimer's disease Prog Brain Res 172 2008 233 264
58. G. Zhang, H.N. Ásgeirsdóttir, S.J. Cohen, A.H. Munchow, M.P. Barrera, and R.W. Stackman Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL/6J mice Neuropharmacology 64 2013 403 413
59. M. Savli, A. Bauer, M. Mitterhauser, Y. Ding, A. Hahn, T. Kroll, and et al. Normative database of the serotonergic system in healthy subjects using multi-tracer PET Neuroimage 63 2012 447 459
60. G. Rammes, M. Eder, H.U. Dodt, E. Kochs, and W. Zieglgänsberger Long-term depression in the basolateral amygdala of the mouse involves the activation of interneurons Neuroscience 107 2001 85 97
61. M.A. Vicente, and H. Zangrossi Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment Neuropharmacology 79 2014 127 135
62. D.G. Rainnie Serotonergic modulation of neurotransmission in the rat basolateral amygdala J Neurophysiol 82 1999 69 85
63. G.E. Stutzmann, and J.E. LeDoux GABAergic antagonists block the inhibitory effects of serotonin in the lateral amygdala: A mechanism for modulation of sensory inputs related to fear conditioning J Neurosci 19 1999 RC8
64. R.Y. Shen, and R. Andrade 5-Hydroxytryptamine2 receptor facilitates GABAergic neurotransmission in rat hippocampus J Pharmacol Exp Ther 285 1998 805 812
65. G. Piñeyro, and P. Blier Autoregulation of serotonin neurons: Role in antidepressant drug action Pharmacol Rev 51 1999 533 591
66. K.B. Fink, and M. Göthert 5-HT receptor regulation of neurotransmitter release Pharmacol Rev 59 2007 360 417
67. C.C. Meltzer, J.C. Price, C.A. Mathis, M.A. Butters, S.K. Ziolko, E. Moses-Kolko, and et al. Serotonin 1A receptor binding and treatment response in late-life depression Neuropsychopharmacology 29 2004 2258 2265
68. W.C. Drevets, E. Frank, J.C. Price, D.J. Kupfer, D. Holt, P.J. Greer, and et al. PET imaging of serotonin 1A receptor binding in depression Biol Psychiatry 46 1999 1375 1387
69. W.C. Drevets, E. Frank, J.C. Price, D.J. Kupfer, P.J. Greer, and C. Mathis Serotonin type-1A receptor imaging in depression Nucl Med Biol 27 2000 499 507
70. R. Lanzenberger, W. Wadsak, C. Spindelegger, M. Mitterhauser, E. Akimova, L. Mien, and et al. Cortisol plasma levels in social anxiety disorder patients correlate with serotonin-1A receptor binding in limbic brain regions Int J Neuropsychopharmacol 13 2010 1129 1143
71. R. Sladky, A. Höflich, M. Küblböck, C. Kraus, P. Baldinger, E. Moser, and et al. Disrupted effective connectivity between the amygdala and orbitofrontal cortex in social anxiety disorder during emotion discrimination revealed by dynamic causal modeling for fMRI [published online ahead of print October 9] Cereb Cortex 2013
72. A. Hahn, P. Stein, C. Windischberger, A. Weissenbacher, C. Spindelegger, E. Moser, and et al. Reduced resting-state functional connectivity between amygdala and orbitofrontal cortex in social anxiety disorder Neuroimage 56 2011 881 889
73. C. Spindelegger, R. Lanzenberger, W. Wadsak, L.K. Mien, P. Stein, M. Mitterhauser, and et al. Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders Mol Psychiatry 14 2009 1040 1050
74. J. Dai, H. Han, M. Tian, J. Cao, J. Xiu, N. Song, and et al. Enhanced contextual fear memory in central serotonin-deficient mice Proc Natl Acad Sci U S A 105 2008 11981 11986
75. B.J. Catlow, S. Song, D.A. Paredes, C.L. Kirstein, and J. Sanchez-Ramos Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning Exp Brain Res 228 2013 481 491
76. P.M. Fisher, C.C. Meltzer, S.K. Ziolko, J.C. Price, E.L. Moses-Kolko, S.L. Berga, and A.R. Hariri Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity Nat Neurosci 9 2006 1362 1363
77. G. Griebel, G. Perrault, and D.J. Sanger A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety Neuropharmacology 36 1997 793 802
78. M.J. Millan The neurobiology and control of anxious states Prog Neurobiol 70 2003 83 244
79. X. Li, M.A. Frye, and R.C. Shelton Review of pharmacological treatment in mood disorders and future directions for drug development Neuropsychopharmacology 37 2012 77 101
80. P. Blier, and N.M. Ward Is there a role for 5-HT1A agonists in the treatment of depression? Biol Psychiatry 53 2003 193 203
81. T. Outhred, B.E. Hawkshead, T.D. Wager, P. Das, G.S. Malhi, and A.H. Kemp Acute neural effects of selective serotonin reuptake inhibitors versus noradrenaline reuptake inhibitors on emotion processing: Implications for differential treatment efficacy Neurosci Biobehav Rev 37 2013 1786 1800
82. A. Pringle, M. Browning, P.J. Cowen, and C.J. Harmer A cognitive neuropsychological model of antidepressant drug action Prog Neuropsychopharmacol Biol Psychiatry 35 2011 1586 1592